Abstract:<h3 class="Heading">Background</h3><p class="Para">N6-Methyladenosine (m<sup>6</sup>A), the most prevalent modification in mammalian mRNA, plays important roles in numerous biological processes. Several m<sup>6</sup>A associated proteins such as methyltransferase like 3 (METTL3), methyltransferase like 14 (METTL14), α-ketoglutarate-dependent dioxygenase AlkB homolog 5 (ALKBH5) and YTH domain containing 2 (YTHDC2) are involved in the regulation of spermatogenesis and oogenesis. However, the role of the first detected m6A demethylase, fat mass and obesity associate protein (FTO), in germ cells remains elusive. Elucidation of FTO roles in the regulation of germ cell fate will provide novel insights into the mammalian reproduction.</p><h3 class="Heading">Methods</h3><p class="Para">Mouse GC-1 spg cells were treated with the ester form of meclofenamic acid (MA2) to inhibit the demethylase activity of FTO. The cellular m<sup>6</sup>A and m<sup>6</sup>A<sub>m</sub> level were analyzed through high performance liquid chromatography combined with tandem mass spectrometry (HPLC/MS-MS). The cell apoptosis was detected via TUNEL and flow cytometry. The cell proliferation was detected through EdU and western blot. The mRNA level of core cyclin dependent kinases (CDKs) was quantified via q-PCR. RNA decay assay were performed to detect RNA stability. Dual fluorescence assay was conducted to study whether MA2 affects the expression of CDK2 dependent on the m<sup>6</sup>A modification at 3'UTR.</p><h3 class="Heading">Results</h3><p class="Para">MA2 significantly increased the cellular m<sup>6</sup>A level and down-regulated the expression of CDK1, CDK2, CDK6 and CdC25a, resulting in arrest of G1/S transition and decrease of cell proliferation. MA2 downregulated CDK2 mRNA stability. Additionally, mutation of the predicted m<sup>6</sup>A sites in the Cdk2–3'UTR could mitigated the degradation of CDK2 mRNA after MA2 treatment.</p><h3 class="Heading">Conclusion</h3><p class="Para">MA2 affected CDKs expression through the m<sup>6</sup>A-dependent mRNA degradation pathway, and thus repressed spermatogonial proliferation.</p>

FTO Knockout Causes Chromosome Instability and G2/M Arrest in Mouse GC-1 Cells.

Fat Mass and Obesity-Associated Factor (Fto)-Mediated N6-methyladenosine Regulates Spermatogenesis in an Age-Dependent Manner.

SPI1-induced Downregulation of FTO Promotes GBM Progression by Regulating Pri-Mir-10a Processing in an M6a-Dependent Manner

FTO regulates adipogenesis by controlling cell cycle progression via mA-YTHDF2 dependent mechanism.

FTO Regulates the DNA Damage Response Via Effects on Cell-Cycle Progression.

FTO regulates myoblast proliferation by controlling CCND1 expression in an m<SUP>6</SUP>A-YTHDF2-dependent manner

FTO regulates myoblast proliferation by controlling CCND1 expression in an m6A-YTHDF2-dependent manner

Meclofenamic acid represses spermatogonial proliferation through modulating m 6 A RNA modification

Dynamic Effects of Fto in Regulating the Proliferation and Differentiation of Adult Neural Stem Cells of Mice.

FTO Mediates LINE1 M6a Demethylation and Chromatin Regulation in Mescs and Mouse Development

Recruitment of the m6A/Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48

Meclofenamic acid represses spermatogonial proliferation through modulating m6A RNA modification

DNA Damage-Mediated FTO Downregulation Promotes CRPC Progression by Inhibiting FOXO3a Via an M6a-Dependent 6 A-dependent Mechanism

Recruitment of the m6A/m6Am demethylase FTO to target RNAs by the telomeric zinc finger protein ZBTB48

Effect of demethyltransferase FTO on tumor progression

N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability

FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis

FTO levels affect RNA modification and the transcriptome

FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis

N6-methyladenosine Demethyltransferase FTO Mediated M6a Modification of Estrogen Receptor Alpha in Non-Small Cell Lung Cancer Tumorigenesis

N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1 alpha signalling axis